109 related articles for article (PubMed ID: 31029887)
1. Tomato lectin-modified nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine: Targeting intestinal M cells following peroral administration.
Long P; Zhang Q; Xue M; Cao G; Li C; Chen W; Jin F; Li Z; Li R; Wang X; Ge W
Biomed Pharmacother; 2019 Jul; 115():108886. PubMed ID: 31029887
[TBL] [Abstract][Full Text] [Related]
2. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
[TBL] [Abstract][Full Text] [Related]
3. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes.
Ge W; Hu PZ; Huang Y; Wang XM; Zhang XM; Sun YJ; Li ZS; Si SY; Sui YF
Oncol Rep; 2009 Oct; 22(4):915-20. PubMed ID: 19724873
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine].
Ge W; Sun YJ; Li Y; Zhang SH; Zhang XM; Huang Y; Hu PZ; Sui YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):457-60. PubMed ID: 18466701
[TBL] [Abstract][Full Text] [Related]
5. Preparation of a new combination nanoemulsion-encapsulated MAGE1-MAGE3-MAGEn/HSP70 vaccine and study of its immunotherapeutic effect.
Zhang X; Huang Y; Li X; Wang Y; Yuan Y; Li M
Pathol Res Pract; 2020 Jun; 216(6):152954. PubMed ID: 32321658
[TBL] [Abstract][Full Text] [Related]
6. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
[TBL] [Abstract][Full Text] [Related]
7. MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo.
Ge W; Sui YF; Wu DC; Sun YJ; Chen GS; Li ZS; Si SY; Hu PZ; Huang Y; Zhang XM
Cancer Immunol Immunother; 2006 Jul; 55(7):841-9. PubMed ID: 16155756
[No Abstract] [Full Text] [Related]
8. [Preliminary observation on antitumor effect of HPV58 composite DNA vaccine].
Wang H; Yu JY; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):523-7. PubMed ID: 24284225
[TBL] [Abstract][Full Text] [Related]
9. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
[TBL] [Abstract][Full Text] [Related]
10. Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma.
Cintolo JA; Datta J; Xu S; Gupta M; Somasundaram R; Czerniecki BJ
Melanoma Res; 2016 Feb; 26(1):1-11. PubMed ID: 26451873
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.
Ravindranath MH; Brazeau SM; Morton DL
Experientia; 1994 Jul; 50(7):648-53. PubMed ID: 8033972
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine.
Chang EY; Chen CH; Ji H; Wang TL; Hung K; Lee BP; Huang AY; Kurman RJ; Pardoll DM; Wu T
Int J Cancer; 2000 Jun; 86(5):725-30. PubMed ID: 10797297
[TBL] [Abstract][Full Text] [Related]
13. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
[TBL] [Abstract][Full Text] [Related]
14. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
Zhou WZ; Kaneda Y; Huang S; Morishita R; Hoon D
Gene Ther; 1999 Oct; 6(10):1768-73. PubMed ID: 10516727
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response.
Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; He L; Wang J; Cao X
J Cancer Res Clin Oncol; 2001 Dec; 127(12):718-26. PubMed ID: 11768611
[TBL] [Abstract][Full Text] [Related]
16. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy.
Huang C; Yu H; Wang Q; Yang G; Ma W; Xia D; Chen X; Yi P; Shen F; Zheng H; Cao X
Immunol Lett; 2005 Oct; 101(1):71-80. PubMed ID: 15908014
[TBL] [Abstract][Full Text] [Related]
17. A novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunity.
Ma W; Yu H; Wang Q; Jin H; Solheim J; Labhasetwar V
J Clin Immunol; 2004 May; 24(3):294-301. PubMed ID: 15114060
[TBL] [Abstract][Full Text] [Related]
18. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
[TBL] [Abstract][Full Text] [Related]
19. Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.
Ravindranath MH; Kelley MC; Jones RC; Amiri AA; Bauer PM; Morton DL
Int J Cancer; 1998 Jan; 75(1):117-24. PubMed ID: 9426699
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of oral microparticulate ovarian cancer vaccines.
Tawde SA; Chablani L; Akalkotkar A; D'Souza C; Chiriva-Internati M; Selvaraj P; D'Souza MJ
Vaccine; 2012 Aug; 30(38):5675-81. PubMed ID: 22750042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
